What is the appropriate aspirin dose to administer within the first six hours after coronary artery bypass grafting (CABG)?

Aspirin Dose Within 6 Hours Post-CABG

For patients undergoing CABG, aspirin should be started within 6 hours postoperatively at a dose of 100-325 mg daily to reduce saphenous vein graft closure, with 81 mg daily being a reasonable and widely accepted option that minimizes bleeding risk while maintaining efficacy. 1

Recommended Dosing Strategy

The most direct guideline recommendation states: "For patients undergoing coronary artery bypass grafting, aspirin should be started within 6 hours after surgery to reduce saphenous vein graft closure. Dosing regimens ranging from 100 to 325 mg daily for 1 year appear to be efficacious." 1 This is a Class I recommendation with Level of Evidence A, representing the strongest possible evidence grade.

Practical Dose Selection

While the evidence-based range is 100-325 mg, the 2023 AHA/ACC performance measures explicitly state that 81 mg daily meets the requirements for optimal post-CABG aspirin therapy 2. This lower dose is:

• Associated with less bleeding compared to higher maintenance doses
• Widely used in clinical practice after both CABG and PCI
• Supported by evidence showing 81 mg is reasonable in preference to higher doses 3

Critical Timing Considerations

The 6-hour window is crucial for graft patency. Early aspirin administration:

• Reduces operative morbidity and mortality 4
• Improves saphenous vein graft patency, particularly during the first postoperative year 2
• Does not significantly increase bleeding risk when given at this timepoint 5, 6

Clinical Algorithm for Post-CABG Aspirin

At 6 hours post-CABG, assess:

1. Mediastinal drainage volume: If excessive ongoing bleeding (typically >200 mL/hour), delay aspirin and reassess hourly
2. Coagulation status: If coagulopathy present, correct first
3. Hemodynamic stability: Ensure patient is stable

If no contraindications exist:

• Administer non-enteric coated aspirin 81-325 mg (most commonly 81 mg or 300 mg loading dose)
• Continue 81 mg daily indefinitely thereafter

If aspirin cannot be given at 6 hours due to bleeding:

• Start as soon as bleeding is controlled 7
• Do not delay beyond 24 hours unless absolutely necessary

Evidence Supporting Safety

Recent research directly addresses bleeding concerns: A 2025 study of 160 CABG patients receiving 300 mg aspirin within 6 hours showed no significant difference in drainage output, transfusion requirements, re-exploration rates, or pericardial effusion compared to delayed administration 5. Similarly, a 2015 study found that aspirin given 1 hour post-CABG (versus 6 hours) showed no increased bleeding risk 6.

Special Populations

For patients with ACS undergoing CABG:

• Resume P2Y12 inhibitor therapy postoperatively in addition to aspirin to complete 12 months of dual antiplatelet therapy 8
• This applies even if clopidogrel or ticagrelor was stopped pre-operatively

For patients with chronic coronary syndrome:

• Recent evidence suggests 300 mg aspirin may provide better graft patency than 75 mg 9
• However, 81 mg remains acceptable per guidelines

Common Pitfalls to Avoid

• Do not use enteric-coated aspirin initially - guidelines specifically recommend non-enteric coated formulation 4, 3
• Do not routinely delay beyond 6 hours - the evidence for graft patency benefit is strongest with early administration
• Do not withhold aspirin due to theoretical bleeding concerns - multiple studies confirm safety when given appropriately 5, 6, 10
• Do not forget to continue aspirin indefinitely - this is a lifelong therapy for graft patency 11, 1